Cardiogenerics, Inc.

Cardiogenerics offers cardiac surgery products at 50% cost of brand devices and a fraction of the hospital waste. Sustainable solutions to medical costs!

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Ann Arbor, MI, USA
  • Currency USD
  • Founded June 2018
  • Employees 2
  • Incorporation Type C-corp
  • Website cardiogenerics.com

Company Summary

The biggest unmet need in medical devices is cost effective devices with equivalent performance. CardioGenerics will offer off patent medical devices designed for reprocessing (cleaning and resterilization) which reduces both hospital cost and waste. We target $3.6 billion markets. A heart stabilizer has removable, single use suction pods and an articulating arm designed and tested for multiple uses. Same performance, half the cost.

Team

  • William G O'Neill
    VP R&D

    VP R&D CardioGenerics, Minneapolis, MN
    Owner and VP R&D, Global Device Solutions, which provides medical device engineering consulting
    services.
    Technical Fellow, CVRx: Designed catheter delivery systems for implanting a stimulating electrode
    Technical Fellow, J&J Ethicon: Designed minimally invasive instruments.
    Previous Roles: Designed perfusion products for Medtronic and Terumo.
    B.S. and M.S., Mechanical Engineering Michigan State Unive

  • William O'Neill

  • Jay Gottleib
    Advisor

    Jay D. Gottleib recently retired after a distinguished 35 year career with Kimberly-Clark Corporation. From 2016 - 2019, Jay was President, North America Consumer Tissue, with total responsibility for the $4 billion KLEENEX®, COTTONELLE®, SCOTT® and VIVA® brands - with direct accountability for Profit & Loss, Marketing, Product Development, Engineering, and Supply Chain

  • Bob Dolan
    VP Sales

    Bob Dolan has had a 35 year career in the software industry. Bob held various positions focusing on sales and sales management for early stage software companies. For the past 15 years Bob held the position of VP Global Sales and VP Global Alliances for Kinaxis (www.Kinaxis.com). During Bob’s tenure, Kinaxis successfully executed an IPO. 

  • Mary Boylan M.D.
    Medical Advisor

    Dr. Boylan is a practicing cardiac surgeon at St. Lukes Hospital in Duluth, MN. Dr. Boylan has been performing beating heart coronary artery bypass graft surgery for over twenty years.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free